Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Elstar Therapeutics Inc.

www.elstartherapeutics.com

Latest From Elstar Therapeutics Inc.

Venture Funding Deals: BioNTech's Big Money Leads January Financings

BioNTech's $270m Series A round was the biggest start-up financing in January, but sizeable rounds also were raised by Centrexion ($67m), Eureka ($60m) and Pandion ($58m).

StartUps and SMEs Financing
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Elstar Therapeutics Inc.
  • Senior Management
  • Steve Arkinstall, Pres. & CEO
    Patricia Deware, CFO
    Andreas Loew, PhD, EVP, Oncology & CSO
    Peter Williams, CBO
  • Contact Info
  • Elstar Therapeutics Inc.
    Phone: (617) 917-4980
    840 Memorial Dr. 4th Fl.
    Riverside Tech
    Cambridge, MA 02139
    USA
UsernamePublicRestriction

Register